RxDoctor Payments Data

David Holt, PA

Physician Assistant · Fort Smith, ARNPI 1912533589

Payments from drug & device makers

$3,531in general payments, 2019–2025

Across 170 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$650
  • Biohaven Pharmaceuticals, Inc.$399
  • Collegium Pharmaceutical, Inc.$373
  • AbbVie$264
  • Eisai Inc.$220
  • Paratek Pharmaceuticals, Inc.$212
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,531100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,531 in reported general payments places this provider in the 85th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$96,475
Medicare patients
498
Services billed
1,910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,134$65,018
RelistorMethylnaltrexone Bromide19$45,165
LinzessLinaclotide58$43,324
MovantikNaloxegol Oxalate57$24,541
Buprenorphine76$19,513
BelbucaBuprenorphine Hcl24$18,160
Naloxone Hcl153$11,412
Gabapentin497$6,031
Lidocaine40$5,481
Pregabalin200$5,018
Diclofenac Sodium106$4,261
Tizanidine Hcl495$4,213
Tramadol Hcl252$2,374
Ondansetron OdtOndansetron55$1,887
Baclofen113$1,620

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$650$45,16519 claims
AbbVieLinzess$264$43,32458 claims
Redhill Biopharma Inc.Movantik$44$24,54157 claims
Collegium Pharmaceutical, Inc.Belbuca$373$18,16024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →